Notre actualité
Nous sommes heureux de vous annoncer que le Ministère de l’Enseignement Supérieur et de la Recherche a accordé à HCS Pharma l’agrément au Crédit d’Impôt Recherche (CIR) jusqu’en 2023, en regard de nos activités de R&D. For non-french readers, the CIR (Research Tax Credit) concept is explain here. Our customers can Read more…
We are pleased and proud to welcome Dr Philippe Manivet and Dr Anthony Trezeibre in our Scientific Advisory Board. We are developing new innovative projects with them around our BIOMIMESYS technology. Because our BIOMIMESYS technology is requested in different fields and we want to stay at the forefront of innovation, Read more…
We wish you a great year 2021, with great success in your all your projects. Here at HCS Pharma, we strongly believed that 3D cell culture in adequat medium is a key factor for successful drug discovery projects. To help you as efficiently as possible we have modified this website. Read more…
Step by step we are getting closer to 2021, after a very particular and, for some of us, very difficult 2020 year. 2021 will be THE year of 3D cell culture in many research applications such as drug discovery for complex diseases or cancers. We will be happy to facilitate Read more…
We are very pleased to announce that Meryl, our first CIFRE PhD student, defended his doctoral thesis last week! His PhD work was dealing with the use of pluripotent stem cells to study liver diseases. He has also developed an innovative model to obtain liver organoïds in our BIOMIMESYS® product. Read more…
HCS Pharma is pleased to present the whole range of BIOMIMESYS® Products. All our scientific team is ready to support you in using our 3D organ/tissue-specific cell-culture technology. Rediscover your cells in real in vitro 3D-culture conditions with our special evaluation plate format . You can find our presentation in Read more…
On the occasion of the breast cancer awareness month, HCS Pharma is willing to thank all researchers working in the field to better understand the pathophysiology of disease, with the objective to find more efficient anti-cancer therapies. We would like to warmly thank the researchers with whom we are collaborating Read more…
Vaihere Cheung obtained her technology A-level (STL) in 2018 at La Mennais, in French Polynesia. Then she came to metropolitan France to reach a technician diploma in Biological engineering, specialized in biological and biochemical analysis, at the University of Lyon. During her studies, Vaihere did an internship in HCS Pharma Read more…
It’s pleasure to welcome Thomas in our team. After a four-month internship at the CrCHUM (Centre de recherche du Centre Hospitalier de l’Université de Montréal, Canada) in the field of microfluidic personalized medicine for prostate cancer, he joined us in September for a six- months-internship, as part of his Master’s Read more…
We are really proud to work on a real partnership with the team of Tokyo Future Style (TFS) Taïwan for almost a year now. Joseph Chou, member of our business advisory board and Pr John Lo, member of our scientific advisory board, have fully understood the value of BIOMIMESYS® our Read more…
We are very pleased to welcome Sandrine in HCS Pharma team. With multiple decades in cell culture products sales in the life sciences market for various major companies, Sandrine PONCET brings to HCS Pharma an essential asset to develop and support BIOMIMESYS® sales in the national and international academic and Read more…
You may have noticed on our website: we have changed our logo this summer, and it is the most visible part of our strategic development. Of course, we are always experts in HCS and cell imaging but, for us, it is the perfect time to show our deep expertise in Read more…
We are very pleased to welcome Julien in our team. Julien has a bachelor’s degree in control and expertise analysis. He started his carrer in the pharmaceutical industry and he continued in chemical industry where he acquired strong skills in quality management. Now he has joined HCS Pharma to work Read more…
Vaihere Cheung obtained her technology baccalaureate in Sciences and Laboratory Techniques (STL) in 2018 at La Mennais, in French Polynesia. Afterwards, she came to Metropolitan France to pursue her studies in biological engineering at the Technological Institute in Lyon University. In this context, she performed an internship in two laboratories Read more…
Among 370 applications from 54 countries, I am proud to be selected with 9 other start-ups for Female Founder Challenge organized by Vivatechnology & 50inTech. We are to women frmn France. “In Europe, 92% of the funds were invested in startups founded by men. The tech sector needs to be Read more…
As we are involved in some very interesting projects, we have the chance to work with amazing specialists in many field. All these people help us to make the BIOMIMESYS® technology better, easier to use and well adapted to their work. We asked them to explain why they use BIOMIMESYS® Read more…
Dear all, We hope this email finds you, your family and colleagues well! We are available to discuss with you: about your needs in high content screening/analysis services. We would be happy to organise videoconferences and phone calls to see how imaging can foster your R&D, by testing the safety Read more…
Our BIOMIMESYS® products are now available in the Dominique Dutscher’s catalogue. We are very happy to work with such a famous company ! Founded in 1982 in Alsace (France) Dominique Dutscher SAS is specialized in the distribution of laboratory consumables and equipment for research, biotechnology and health. We share with Read more…
Immersive technologies (XR) are playing an increasingly important role in many areas of the healthcare sector. In HCS Pharma we monitor this progress and we have used these technologies many times, for example at the installation of our robotic platform. Then we were very happy when Laval Virtual, one of Read more…
Elisa Moya started her bachelor’s degree in 2013, in Biological Sciences, at the University of Granada, Spain. During her career period, in 2015, she studied one year in Portugal (Erasmus+). Moreover, in the summer 2016, she participated during 3 months in a research project dealing with Alzheimer’s disease in Newcastle Read more…
Dr. Karine Hannebicque has joined our Scientific Advisory Board. She is a surgeon in breast cancer and reconstructive surgery working in Oscar Lambret Center in the Department of breast oncology since 2013. She is also Medical Coordinator of the Ambulatory Surgery Unit since 2018. After her Internship in Obstetrics & Read more…
We are really happy to welcome Prof. Lo in our Scientific Advisory Board. Prof. Lo has a huge experiment in hepatitis infection and liver diseases with more than 120 publications in this field. With help of Joseph Chou (CEO of Tokyo Future Style Taiwan), Pr Lo leads all R&D programs Read more…
As part of the validation of her Master’s degree in biotechnology (University of Lille), specializing in cellular and molecular engineering, Elise recently joined HCS Pharma. After having completed three internships from one to four months in the fields of immunology and microbiology, in France and abroad, she joined the team Read more…